Medicine and Dentistry
Abscess
25%
Acetylsalicylic Acid
16%
Adverse Event
50%
Antibiotics
25%
Awareness
25%
Biopsy Technique
25%
Brain Biopsy
25%
Cardiac Dysrhythmia
50%
Cardiovascular Disease
50%
Cardiovascular System
20%
Cell Therapy
50%
Central Nervous System
50%
Chemoradiotherapy
50%
Chimeric Antigen Receptor
50%
Chimeric Antigen Receptor T-Cell Immunotherapy
40%
COVID-19
50%
Cytokine Release Syndrome
50%
Diseases
60%
Etanercept
25%
Hazard Ratio
16%
Heart Graft
25%
Hospitalist
100%
Immune Checkpoint Inhibitor
66%
Immune-Related Adverse Events
61%
Immunity
60%
Immunoglobulin
50%
Immunotherapy
60%
Inflammatory Arthritis
25%
Lung
16%
Malignant Neoplasm
41%
Mean Corpuscular Hemoglobin
50%
Medicine
50%
Neoplasm
33%
Non Small Cell Lung Cancer
50%
Odds Ratio
16%
Oncology
58%
Orthotopic Heart Transplantation
50%
Patient Communication
25%
Pneumonia
100%
Rheumatoid Arthritis
25%
Serositis
20%
Solid Malignant Neoplasm
58%
Surgical Risk
50%
T Cell
20%
Thorax Surgery
16%
Thyroid Disease
25%
Transplantation
16%
Tumor Antigen
20%
Vasoplegia
50%
Ventricular Assist Device
16%
Keyphrases
Abscess
25%
Agile Processes
10%
All-cause Mortality
8%
Atrial Fibrillation Arrhythmia
10%
Brain Biopsy
25%
Central Nervous System
50%
Chemoradiation
16%
Concurrent Chemoradiation
50%
Confidence Interval
16%
Convexity
25%
Disability
25%
Empiric Antibiotics
25%
Etanercept
25%
Fibroinflammatory Disease
25%
Flutter
10%
Focal Neurological Deficit
25%
Hazard Ratio
16%
Hospital-Based Clinical Medicine
50%
Hospitalized COVID-19
50%
Hypochromia
50%
Imaging Findings
25%
Immune Checkpoint Inhibitors
50%
Immunoglobulin
50%
Interstitial Lung Disease
8%
Iron Insufficiency
16%
Irreversible Organ Damages
25%
Leptomeningeal
50%
Leptomeningeal Enhancement
25%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
50%
Mean Corpuscular Hemoglobin Concentration
33%
Multivariable
12%
Neoplasia
25%
Nondiagnostic
25%
Older Men
25%
Palantir
10%
Patient Condition
25%
Pneumonitis
50%
Prolonged Corrected QT Interval
10%
Prompt Diagnosis
25%
Prompt Treatment
25%
Rheumatoid Arthritis
25%
Risk Factors
12%
Structure Performance
16%
Sustainable Adoption
10%
Syntropy
10%
Vasoplegic Syndrome
50%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
50%
Anemia
25%
Atrial Fibrillation
7%
Cardiovascular Disease
50%
Chimeric Antigen Receptor
50%
Colitis
7%
Congestive Heart Failure
57%
Cytokine
7%
Cytokine Release Syndrome
50%
Diseases
7%
Heart Arrhythmia
50%
Heart Left Ventricle Failure
7%
Heart Ventricle Arrhythmia
7%
Hypotension
7%
Immune Checkpoint Inhibitor
14%
Immunotherapy
57%
Inflammation
14%
Interleukin Derivative
7%
Iron
25%
Malignant Neoplasm
14%
Myocarditis
7%
Natriuretic Factor
25%
Neoplasm
7%
Pembrolizumab
7%
Remission
14%
Side Effect
7%
Solid Malignant Neoplasm
50%
Supraventricular Tachycardia
7%
Systolic Heart Failure
50%
Tachycardia
7%
Torsade Des Pointes
7%
Toxicity and Intoxication
7%
Tumor Antigen
14%